Aleve(ALEVETABS)
Naproxen sodium
Aleve and ALEVETABS are different trade names for the same medicine.
This medicine should always be used exactly as described in this patient leaflet or as directed by your doctor or pharmacist.
Aleve belongs to a group of nonsteroidal anti-inflammatory drugs (NSAIDs) that, by reversibly inhibiting prostaglandin synthesis, have analgesic, antipyretic, and anti-inflammatory effects. Aleve reduces the severity of pain, lowers fever, and inhibits inflammatory reactions. Aleve has a rapid and long-lasting effect.
Treatment of mild to moderate pain, such as:
Before starting to take Aleve, you should discuss it with your doctor or pharmacist.
Patient who have had gastrointestinal side effects in the past, especially if they are elderly, should inform their doctor about any worrying abdominal symptoms (including gastrointestinal bleeding).
This medicine belongs to a group of medicines (nonsteroidal anti-inflammatory drugs) that may adversely affect fertility in women. This effect is reversible and disappears after the end of therapy.
Aleve, like other NSAIDs, due to its anti-inflammatory and antipyretic effects, may mask the symptoms of another disease, making its diagnosis more difficult.
Taking such medications as Aleve may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. This risk increases with long-term use of high doses of the medicine. You should not take higher doses or use the medicine for longer than recommended (up to 10 days).
In case of heart problems, a history of stroke, or suspected risk of these disorders (e.g., high blood pressure, diabetes, high cholesterol, smoking), you should discuss the treatment with your doctor or pharmacist.
You should avoid taking naproxen sodium with other NSAIDs, including selective cyclooxygenase-2 inhibitors.
You should tell your doctor or pharmacist about all the medicines you are taking, have recently taken, or plan to take. You should inform your doctor or pharmacist if you are taking any of the following medicines:
Effect on laboratory tests
It has been found that naproxen sodium affects the measurement of 17-ketogenic steroids and 5-hydroxyindoleacetic acid (5-HIAA) in urine.
You should tell your doctor about all the medicines you have taken recently, including those that are available without a prescription.
Food may slightly delay the absorption of the active substance.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before taking this medicine.
You should not take Aleve if you are in the last 3 months of pregnancy, as it may harm the unborn child or cause complications during delivery. It may cause kidney and heart problems in the unborn child. It may increase the risk of bleeding in you and your child and cause prolongation or delay of labor. During the first 6 months of pregnancy, you should not take the medicine unless it is absolutely necessary and recommended by your doctor. If treatment is necessary during this period or when trying to conceive, you should use the lowest possible dose for the shortest possible time. From the 20th week of pregnancy, Aleve may cause kidney problems in the unborn child if taken for more than a few days. This may lead to a decrease in the amount of amniotic fluid surrounding the child (oligohydramnios) or narrowing of the arterial duct (ductus arteriosus) in the child's heart. If treatment is necessary for a longer period, your doctor may recommend additional monitoring.
Do not take this medicine in the last trimester of pregnancy.
You should avoid taking Aleve while breastfeeding, as naproxen passes into breast milk.
Naproxen may affect fertility. This effect is reversible and disappears after the end of therapy.
While taking Aleve, you may experience side effects such as drowsiness, dizziness, insomnia, which may affect your ability to drive or operate machinery.
Therefore, patients taking Aleve should observe their reactions before driving or operating machinery.
One tablet contains 20 mg of sodium, which corresponds to the sodium content in one slice of bread.
The amount of sodium in a low-sodium diet is limited to ≤1.2 g (50 mmol) per day.
This medicine should always be taken exactly as described in the patient leaflet or as directed by your doctor or pharmacist. In case of doubt, you should ask your doctor or pharmacist.
Method of administration
Each dose should be taken with a glass of water – the medicine can be taken independently of meals. Food may slightly slow down the absorption of the medicine.
Recommended dose
Single dose: 220 mg, every 8 to 12 hours until symptoms disappear. In some patients, taking an initial dose of 440 mg, followed by 220 mg after 12 hours, may increase the analgesic effect.
You should not exceed the daily dose of 660 mg, unless your doctor decides otherwise.
Elderly patients
Elderly patients are more susceptible to side effects, and their dose should be adjusted accordingly.
Aleve should not be taken for more than 10 days for pain or more than 3 days for fever, unless under medical supervision. If symptoms persist or worsen, you should consult your doctor.
Children under 16 years of age should not take Aleve, unless recommended by a doctor.
Significant overdose is characterized by dizziness, drowsiness, abdominal pain, discomfort in the abdominal cavity, heartburn, nausea, vomiting, transient liver function disorders, increased risk of bleeding, kidney function disorders, metabolic acidosis, shortness of breath, or disorientation. In a few patients, seizures have occurred, but it is not known whether this symptom was related to the use of naproxen.
There have been a few cases of acute, reversible renal failure.
In case of suspected overdose, you should empty the stomach and take standard supportive measures, such as administering activated charcoal. There is no specific antidote.
You should not take a double dose to make up for a missed dose.
If you have any further doubts about taking this medicine, you should ask your doctor or pharmacist.
Like all medicines, Aleve can cause side effects, although not everybody gets them.
Side effects can be minimized by taking the smallest effective dose for the shortest possible time necessary to relieve symptoms.
Nonsteroidal anti-inflammatory drugs have been associated with edema, hypertension, and heart failure.
Taking medications like Aleve may be associated with a small increased risk of heart attack (myocardial infarction) or stroke.
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(may affect less than 1 in 10,000 people):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, PL-02 222 Warsaw, Tel.: + 48 22 49 21 301, Fax: + 48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children. Store in the outer packaging to protect from light.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Aleve is naproxen sodium. One coated tablet contains 220 mg of naproxen sodium.
The other ingredients are: microcrystalline cellulose, povidone K 30, talc, magnesium stearate.
Coating: Opadry Blue YS-1-4215: hypromellose, titanium dioxide, macrogol 8000, indigo carmine (E 132).
The package contains 12 or 24 coated tablets.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Bayer Healthcare SAS
220 Avenue de la Recherche
59120 Loos
France
Bayer Bitterfeld GmbH
Salegaster Chaussee 1
06803 Greppin
Germany
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in France, the country of export: 34009 274 286 9 2
274 286-9
Parallel import authorization number: 98/19
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.